Dicerna Pharmaceuticals, Inc. (DRNA): Price and Financial Metrics
DRNA Price/Volume Stats
| Current price | $38.22 | 52-week high | $40.14 |
| Prev. close | $38.00 | 52-week low | $19.06 |
| Day low | $38.21 | Volume | 5,568,900 |
| Day high | $38.24 | Avg. volume | 1,344,033 |
| 50-day MA | $30.08 | Dividend yield | N/A |
| 200-day MA | $28.68 | Market Cap | 2.99B |
DRNA Stock Price Chart Interactive Chart >
Dicerna Pharmaceuticals, Inc. (DRNA) Company Bio
Dicerna Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers that are genetically defined. The Company is using its proprietary RNA interference technology platform to build a broad pipeline in these therapeutic areas. The company was founded in 2006 and is based in Cambridge, Massachusetts.
DRNA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 0.79% |
| 5-year | 69.87% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 0.00% |
| 2019 | 106.08% |
Continue Researching DRNA
Want to do more research on Dicerna Pharmaceuticals Inc's stock and its price? Try the links below:Dicerna Pharmaceuticals Inc (DRNA) Stock Price | Nasdaq
Dicerna Pharmaceuticals Inc (DRNA) Stock Quote, History and News - Yahoo Finance
Dicerna Pharmaceuticals Inc (DRNA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...